Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases.
- DOI
- 10.1097/icl.0000000000000414
- Published
- 2018-05-01
- Container
- Eye Contact Lens
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/icl.0000000000000414,
title = {Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases.},
author = {Kovalchin J and King B and Masci A and Hopkins E and Fry J and Hou J and Li C and Tenneson K and Weber S and Wolfe G and Collins K and Furfine ES.},
year = {2018},
journal = {Eye Contact Lens},
doi = {10.1097/icl.0000000000000414},
url = {https://doi.org/10.1097/icl.0000000000000414}
}RIS
TY - JOUR TI - Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases. AU - Kovalchin J AU - King B AU - Masci A AU - Hopkins E AU - Fry J AU - Hou J AU - Li C AU - Tenneson K AU - Weber S AU - Wolfe G AU - Collins K AU - Furfine ES. PY - 2018 JO - Eye Contact Lens DO - 10.1097/icl.0000000000000414 UR - https://doi.org/10.1097/icl.0000000000000414 ER -
APA
J, K., B, K., A, M., E, H., J, F., J, H., C, L., K, T., S, W., G, W., K, C., & ES., F. (2018). Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases.. Eye Contact Lens. https://doi.org/10.1097/icl.0000000000000414
Source records
- europe-pmc · retrieved 2026-09-27T02:26:35.644Z